Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mallow Medical is a private Chinese medical device company focused on interventional products for congenital heart disease. The company develops and manufactures cardiac occluder devices used in transcatheter closure procedures, including products for atrial septal defect, ventricular septal defect, patent ductus arteriosus, and patent foramen ovale. Publicly available third-party sources also indicate that Mallow has developed biodegradable occluder technology, including the Pansy biodegradable PFO occluder that has been evaluated in clinical studies. The business appears to be commercially oriented rather than a therapeutics developer, with activity centered on device R&D, production, and clinical use in structural heart disease. It is headquartered in Shanghai and appears to operate as an active private company with related operations in Changzhou.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mallow Medical.